This is the Draft Guidance for Industry Recommendations for Evaluating Donor Eligibility Using Individual Risk-Based Questions to Reduce the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/mSZ3DxY
No comments:
Post a Comment